Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
1(5%)
Results Posted
64%(7 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_2
2
9%
Ph phase_4
4
18%
Ph not_applicable
5
23%
Ph early_phase_1
2
9%
Ph phase_3
2
9%
Ph phase_1
5
23%

Phase Distribution

7

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
2(10.0%)
Phase 1Safety & dosage
5(25.0%)
Phase 2Efficacy & side effects
2(10.0%)
Phase 3Large-scale testing
2(10.0%)
Phase 4Post-market surveillance
4(20.0%)
N/ANon-phased studies
5(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(2)
Completed(11)
Terminated(2)
Other(7)

Detailed Status

Completed11
unknown7
Terminated2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (10.0%)
Phase 15 (25.0%)
Phase 22 (10.0%)
Phase 32 (10.0%)
Phase 44 (20.0%)
N/A5 (25.0%)

Trials by Status

terminated29%
unknown732%
not_yet_recruiting15%
completed1150%
recruiting15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07348510Not Applicable

Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures

Recruiting
NCT06196853Phase 2

Prevention of Cisplatin-induced Nephrotoxicity

Not Yet Recruiting
NCT06134037

Effects of Aminophylline Bolus on TCI (Target Controlled Infusion) Concentrations at Burst Suppression Occurence

Completed
NCT05933642Phase 2

Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults

Unknown
NCT01250496Phase 4

Study With Aminophylline to Attenuate of the Side Effects of Regadenoson

Terminated
NCT01336140Phase 4

Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging

Completed
NCT05552404Phase 4

Postdural Puncture Headache Relief With Aminophylline and SPGB

Completed
NCT03897335Phase 3

Preventing Acute Kidney Injury (AKI) in Pediatric Patients

Unknown
NCT04151381Phase 1

The Effect of Preoperative Aminophylline

Unknown
NCT01759862Not Applicable

Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

Completed
NCT03296579Not Applicable

Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma

Unknown
NCT03152942Phase 1

Progesterone and Aminophylline for the Prevention of Preterm Labour

Unknown
NCT01587027Phase 1

Safety Evaluation of Aminophylline and Methazolamide

Completed
NCT02983422Early Phase 1

Effects of Aminophylline on Renal Function and Urine Volume of AKI Patient

Unknown
NCT02522013Phase 3

Aminophylline for Patients With Post-Dural Puncture Headache

Completed
NCT02270827

A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics

Terminated
NCT01245595Not Applicable

Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery

Completed
NCT01702025Phase 1

Rapid Acclimatization to Hypoxia at Altitude

Completed
NCT01240824Early Phase 1

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

Completed
NCT01530464Phase 1

The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22